Short communication · 30 Dec 2024
Conference abstractPublished 20 Oct 2014
Breast cancer prevention and treatment with oleanane triterpenoids
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer is one of the most frequently diagnosed malignancies and main causes of death in women worldwide. Current treatment options, including surgery, radiotherapy, adjuvant chemotherapy and hormone therapy, may not be adequate to significantly reduce the current morbidity and mortality of breast cancer. The value of natural products and dietary phytochemicals, including triterpenoids, in the prevention and treatment of breast cancer has been established. Oleanolic acid, an oleanane-type pentacyclic triterpenoid, is present in various dietary and medicinal plants. Emerging studies indicate that oleanolic acid and other oleanane triterpenoids modulate multiple intracellular signaling pathways and exhibit chemopreventive and antitumor properties in various cancer models. Several oleanane triterpenoids have been prepared by chemical modification of oleanolic acid moiety, and some of these compounds are considered to be the most potent antiinflammatory and anticarcinogenic triterpenoids known to mankind. This lecture will critically examine the potential role of oleanane triterpenoids in chemoprevention and treatment of mammary cancer. The available preclinical studies using these agents and underlying molecular mechanisms will be presented. Our laboratory has undertaken an extensive research program to investigate mechanism-based chemopreventive effect of a novel oleanane triterpenoid, namely methyl amooranin (AMRMe), employing dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumorigenesis, a classical animal model that resembles human breast cancer. This lecture will present our results on the effects of AMR-Me on mammary tumor incidence, tumor burden, and tumor histopathological indices during DMBA-induced rat mammary carcinogenesis. Mechanistic results demonstrating the regulatory influence of AMR-Me on cell proliferation, apoptosis, proapoptotic protein Bax, antiapoptotic protein Bcl-2, estrogen receptors, Wnt/b-catenin signaling, and nuclear factor-kappaB-mediated inflammatory cascade during experimental mammary tumorigenesis will be analyzed. Several challenges and future directions of research to translate already available impressive preclinical evidence on oleanane triterpenoids to clinical practice of breast cancer prevention and therapy will also be discussed.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 30 Nov 2024
Breast Cancer Understanding Its Causes Diagnosis Treatment and Prevention
Conference abstract · 27 Nov 2023
Public health research contribution to breast and cervical cancer prevention and treatment
Perspective · 25 Mar 2021
Public health research contribution to breast and cervical cancer prevention and treatment.
Conference abstract · 15 Jun 2017
Endocrine treatment of breast cancer: Current concepts to predict and prevent relapse
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Anupam Bishayee”

